Tags

Type your tag names separated by a space and hit enter

[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].
Nervenarzt. 2008 Apr; 79(4):475-9.N

Abstract

Intermittent subcutaneous apomorphine therapy should be considered in patients with advanced Parkinson's disease who experience recurrent off periods despite optimised oral treatment (according to guidelines), for reliable and quick reversal of these otherwise refractory periods. Such treatment is also called rescue therapy. At present, apomorphine injections with the apomorphine pen are underutilised, considering its current indications and contraindications. In the present consensus statement, concepts for the use of apomorphine are presented and discussed based on existing study results, indications, and contraindications. Recommendations for a practical approach are also provided.

Authors+Show Affiliations

Zentrum für Parkinson-Syndrome und Bewegungsstörungen, Paracelsus-Elena-Klinik, Klinikstrasse 16, 34128, Kassel, Deutschland. CTrenkwalder@gmx.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Consensus Development Conference
Journal Article

Language

ger

PubMed ID

18210043

Citation

Trenkwalder, C, et al. "[Intermittent Apomorphine Injections as Rescue Therapy for Advanced Parkinson's Disease. Consensus Statement]." Der Nervenarzt, vol. 79, no. 4, 2008, pp. 475-9.
Trenkwalder C, Boesch S, Ceballos-Baumann A, et al. [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. Nervenarzt. 2008;79(4):475-9.
Trenkwalder, C., Boesch, S., Ceballos-Baumann, A., Dressler, D., Eggert, K., Gasser, T., Honig, H., Müller, T., Reichmann, H., Sieb, J. P., Storch, A., Odin, P., & Poewe, W. (2008). [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. Der Nervenarzt, 79(4), 475-9. https://doi.org/10.1007/s00115-007-2391-0
Trenkwalder C, et al. [Intermittent Apomorphine Injections as Rescue Therapy for Advanced Parkinson's Disease. Consensus Statement]. Nervenarzt. 2008;79(4):475-9. PubMed PMID: 18210043.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement]. AU - Trenkwalder,C, AU - Boesch,S, AU - Ceballos-Baumann,A, AU - Dressler,D, AU - Eggert,K, AU - Gasser,T, AU - Honig,H, AU - Müller,T, AU - Reichmann,H, AU - Sieb,J P, AU - Storch,A, AU - Odin,P, AU - Poewe,W, PY - 2008/1/23/pubmed PY - 2008/6/19/medline PY - 2008/1/23/entrez SP - 475 EP - 9 JF - Der Nervenarzt JO - Nervenarzt VL - 79 IS - 4 N2 - Intermittent subcutaneous apomorphine therapy should be considered in patients with advanced Parkinson's disease who experience recurrent off periods despite optimised oral treatment (according to guidelines), for reliable and quick reversal of these otherwise refractory periods. Such treatment is also called rescue therapy. At present, apomorphine injections with the apomorphine pen are underutilised, considering its current indications and contraindications. In the present consensus statement, concepts for the use of apomorphine are presented and discussed based on existing study results, indications, and contraindications. Recommendations for a practical approach are also provided. SN - 0028-2804 UR - https://www.unboundmedicine.com/medline/citation/18210043/[Intermittent_apomorphine_injections_as_rescue_therapy_for_advanced_Parkinson's_disease__Consensus_statement]_ L2 - https://dx.doi.org/10.1007/s00115-007-2391-0 DB - PRIME DP - Unbound Medicine ER -